Company intelligence / Profile preview

Array Genomics

San Francisco, California, United States

Ownership: Private
Employees: ~20
Development stage: Other

Overview

Array is a biotechnology company leveraging generative artificial intelligence to design programmable genetic medicines. The company's platform focuses on creating synthetic promoters and enhancers that allow for precise, cell-state-specific control of gene expression. By optimizing these regulatory elements, Array aims to improve the safety and efficacy of gene and cell therapies across various therapeutic areas. Their approach combines high-throughput experimental data with deep learning models to navigate the complex landscape of non-coding DNA.

Therapeutic areas: OncologyImmunologyRare Diseases
Modalities: Gene therapyCell therapyDNA-based therapeutics
Industry: Biotech

Beyond the preview

Go deeper on Array Genomics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Array Genomics.

Explore the full profile